Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Numbers Don’t Add Up for IQiyi Stock

IQ stock should get a short-term lift by tapping into more of the Chinese market. The question is if IQiyi has a sustainable business model.

Even Though Aurora Cannabis Has a Future, Lay off ACB Stock for Now

Aurora Cannabis stock is down nearly 50% percent from its March high. But are ACB's wounds self-inflicted or part of larger industry issues?

Why Cronos Group Stock Stands Out in a Sea of Cannabis Sameness

CRON stock is off 50% since February, partly because investors see it like other, larger cannabis companies. Here's why Cronos Group stands out.

3 Threats That Continue to Weigh Netflix Stock Down

Netflix stock has recovered a little from its December 2018 selloff, but NFLX faces numerous threats before it may be considered a buy.

TSLA Stock: Decent Production Numbers Aren’t Enough for a ‘Visionary Company’

Although delivery for its Model 3 hints Tesla is turning into a viable car company, Tesla stock is based on visionary, not ordinary, results.